At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hypoglycemia Prevention During and After Moderate Exercise in Adults With Type 1 Diabetes Using an Artificial Pancreas With Exercise Behavior Recognition
In Brief
A clinical study evaluating EnMPC (Ensemble Model Predictive Control) AP Controller and rMPC (Naïve Model Predictive Control) AP Controller for Type 1 Diabetes Mellitus and Hypoglycemia. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This is a randomized crossover trial with 1:1 randomization to the admission sequence of using the Control AP system (rMPC - Naïve Model Predictive Control) vs. Experimental AP system (EnMPC - Ensemble Model Predictive Control) over approximately 4 months. Eligible participants will proceed to the Data Collection Phase for approximately 28 days, during which they will participate in regimented exercise activities. If the participant collected adequate data during the Data Collection Phase, they will be randomized and undergo the study admissions in the assigned sequence. Each admission is approximately 36 hours in length and will consist of one afternoon of exercise and one without.
Study Details
Timeline
Interventions
This AP controller has the ability to anticipate exercise activity by use of trends seen during the Data Collection Period.
This AP controller does not have the ability to anticipate exercise activity.